Rosacea

LATEST NEWS

Botulinum Toxin With Broadband Light Improves Rosacea-Related Erythema, Flushing

By

Vincent Soreca

Researchers assess the safety and efficacy of botulinum toxin combined with broadband light in treating rosacea-related erythema and flushing.

Ocular Rosacea Is Common and Multisymptomatic

By

Emily Pond

An updated epidemiologic perspective on ocular rosacea is provided.

Rosacea: Skin Disorder or Systemic Disease Process?

By

Aryanna Garber, MS

Current evidence on the links between rosacea and a number of systemic diseases are provided.

Epsolay Cream Now Available for Rosacea

By

Brian Park, PharmD

Epsolay is a topical cream that utilizes a patented technology process to encapsulate benzoyl peroxide 5% within silica-based microcapsules.

Frequency of Rosacea Subtypes

By

Ron Goldberg

Researchers sought to determine the frequency of 4 rosacea subtypes.

Familial Rosacea Prevalence Higher Than Previously Estimated

By

Colby Stong

Data on rosacea intrafamilial transmission in six generations is analyzed.

Ocular Health in Patients With Rosacea and Meibomian Gland Dysfunction

By

Ron Goldberg

Ocular symptoms in patients with rosacea–inflammation, dry eye, and surface dysfunction—are quantified.

Oral Doxycycline for Long-Term Rosacea Management

By

Emily Pond

Relapse and efficacy during long-term SDD40 therapy vs placebo in patients with rosacea is evaluated.

Pulse Dye Laser vs Neodymium:Yttrium-Aluminum-Garnet Laser to Treat Rosacea

By

Ron Goldberg

Researchers sought to compare the outcomes of pulse dye laser (PDL) to neodymium:yttrium-asluminum-garnet (Nd:YAG) laser for treating rosacea.

High Incidence, Prevalence of Depression, Anxiety in Patients With Rosacea

By

Estie Mermelstein, MSN, FNP-BC

The relationship between rosacea and depression and anxiety is examined.